Iain M. Cockburn
Questrom School of Business
595 Commonwealth Ave
Boston, MA 02215
NBER Program Affiliations:
NBER Affiliation: Research Associate
Institutional Affiliation: Boston University
Information about this author at RePEc
NBER Working Papers and Publications
|March 2018||The Impact of Artificial Intelligence on Innovation|
with Rebecca Henderson, Scott Stern: w24449
|January 2018||The Impact of Artificial Intelligence on Innovation: An Exploratory Analysis|
with Rebecca Henderson, Scott Stern
in The Economics of Artificial Intelligence: An Agenda, Ajay Agrawal, Joshua Gans, and Avi Goldfarb, editors
|September 2014||Patents and the Global Diffusion of New Drugs|
with Jean O. Lanjouw, Mark Schankerman: w20492
Published: Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016. "Patents and the Global Diffusion of New Drugs," American Economic Review, American Economic Association, vol. 106(1), pages 136-64, January. citation courtesy of
|December 2013||The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity|
with Murray L. Aitken, Ernst R. Berndt, Barry Bosworth, Richard Frank, Michael Kleinrock, Bradley T. Shapiro
in Measuring and Modeling Health Care Costs, Ana Aizcorbe, Colin Baker, Ernst R. Berndt, and David M. Cutler, editors
|November 2013||Deals Not Done: Sources of Failure in the Market for Ideas|
with Ajay Agrawal, Laurina Zhang: w19679
Published: Ajay Agrawal & Iain Cockburn & Laurina Zhang, 2015. "Deals not done: Sources of failure in the market for ideas," Strategic Management Journal, Wiley Blackwell, vol. 36(7), pages 976-986, 07. citation courtesy of
|October 2013||The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity|
with Murray L. Aitken, Ernst R. Berndt, Barry Bosworth, Richard Frank, Michael Kleinrock, Bradley T. Shapiro: w19487
|March 2013||Price Indexes for Clinical Trial Research: A Feasibility Study|
with Ernst R. Berndt: w18918
Published: June 2014 Price indexes for clinical trial research: a feasibility study
|January 2012||Why are Some Regions More Innovative than Others? The Role of Firm Size Diversity|
with Ajay K. Agrawal, Alberto Galasso, Alexander Oettl: w17793
|May 2011||Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D|
with Scott Stern, Jack Zausner
in Accelerating Energy Innovation: Insights from Multiple Sectors, Rebecca M. Henderson and Richard G. Newell, editors
|April 2011||Comment on "The Confederacy of Heterogeneous Software Organizations and Heterogeneous Developers: Field Experimental Evidence on Sorting and Worker Effort"|
in The Rate and Direction of Inventive Activity Revisited, Josh Lerner and Scott Stern, editors
|August 2010||Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research|
with Jeffrey L. Furman, Margaret K. Kyle, Rebecca M. Henderson
in Contributions in Memory of Zvi Griliches, Jacques Mairesse and Manuel Trajtenberg, editors
|February 2010||The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions|
with Matthew J. Slaughter
in Innovation Policy and the Economy, Volume 10, Josh Lerner and Scott Stern, editors
|January 2010||Not Invented Here? Innovation in Company Towns|
with Ajay Agrawal, Carlos Rosell
in Cities and Entrepreneurship, Edward L. Glaeser, Stuart S. Rosenthal and William C. Strange, organizers
|October 2009||Not Invented Here? Innovation in Company Towns|
with Ajay K. Agrawal, Carlos Rosell: w15437
- Agrawal, Ajay & Cockburn, Iain & Rosell, Carlos, 2010.
"Not Invented Here? Innovation in company towns,"
Journal of Urban Economics,
Elsevier, vol. 67(1), pages 78-89, January.
citation courtesy of
- Ajay Agrawal & Iain Cockburn & Carlos Rosell, 2010.
"Not Invented Here? Innovation in Company Towns,"
in: Cities and Entrepreneurship
National Bureau of Economic Research, Inc.
|November 2007||Patents, Thickets, and the Financing of Early-Stage Firms: Evidence from the Software Industry|
with Megan MacGarvie: w13644
Published: Iain M. Cockburn & Megan J. MacGarvie, 2009.
"Patents, Thickets and the Financing of Early-Stage Firms: Evidence from the Software Industry,"
Journal of Economics & Management Strategy,
Blackwell Publishing, vol. 18(3), pages 729-773, 09.
citation courtesy of
|September 2007||Patents, Thickets and the Financing of Eastly-Stage Firms; Evidence from the Software Industry|
with Megan J. MacGarvie
in Entrepreneurship: Strategy and Structure, Thomas Hellman and Scott Stern, editors
|June 2007||Patents and the Survival of Internet-related IPOs|
with Stefan Wagner: w13146
Published: Wagner, S. & Cockburn, I., 2010.
"Patents and the survival of Internet-related IPOs,"
Elsevier, vol. 39(2), pages 214-228, March.
citation courtesy of
|February 2007||Is the Pharmaceutical Industry in a Productivity Crisis?|
in Innovation Policy and the Economy, Volume 7, Adam B. Jaffe, Josh Lerner and Scott Stern, editors
|October 2006||Entry and Patenting in the Software Industry |
with Megan J. MacGarvie: w12563
Published: Cockburn, I., and MacGarvie, M. “Entry and Patenting in the Software Industry.” Management Science, May 2011. vol. 57 no. 5. citation courtesy of
|September 2006||Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research|
with Jeffrey L. Furman, Margaret K. Kyle, Rebecca Henderson: w12509
|September 2004||Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs|
with Paul D. Chwelos, Ernst R. Berndt: w10746
Published: P. D. Chwelos & E. R. Berndt & I. M. Cockburn, 2008. "Faster, smaller, cheaper: an hedonic price analysis of PDAs," Applied Economics, Taylor and Francis Journals, vol. 40(22), pages 2839-2856. citation courtesy of
|September 2003||Gone But Not Forgotten: Labor Flows, Knowledge Spillovers, and Enduring Social Capital|
with Ajay Agrawal, John McHale: w9950
Published: Agrawal, A., I. Cockburn and J. McHale. "Gone But Not Forgotten: Labor Flows, Knowledge Spillovers and Enduring Social Capital." Journal of Economic Geography 6, 5 (2006): 571-591.
|September 2002||University Research, Industrial R&D, and the Anchor Tenant Hypothesis|
with Ajay Agrawal: w9212
|June 2002||Are All Patent Examiners Equal? The Impact of Examiner Characteristics|
with Samuel Kortum, Scott Stern: w8980
Published: Cohen, Wesley and Steven Merrill (eds.) Patents in the Knowledge-Based Economy. National Academies Press, 2003.
|January 2001||Publicly Funded Science and the Productivity of the Pharmaceutical Industry|
with Rebecca M. Henderson
in Innovation Policy and the Economy, Volume 1, Adam B. Jaffe, Josh Lerner and Scott Stern, editors
|Hedonic Analysis of Arthritis Drugs|
with Aslam H. Anis
in Medical Care Output and Productivity, David M. Cutler and Ernst R. Berndt, editors
|January 2000||Do Patents Matter?: Empirical Evidence after GATT|
with Jean O. Lanjouw: w7495
|September 1999||The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research|
with Rebecca Henderson, Scott Stern: w7359
|January 1999||Balancing Incentives: The Tension Between Basic and Applied Research|
with Rebecca Henderson, Scott Stern: w6882
|May 1998||Hedonic Analysis of Arthritis Drugs|
with Aslam H. Anis: w6574
|January 1998||Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs|
with Ernst R. Berndt, Douglas L. Cocks, Arnold M. Epstein, Zvi Griliches
in Frontiers in Health Policy Research, Volume 1, Alan M. Garber, editor
|September 1997||Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs|
with Ernst R. Berndt, Douglas L. Cocks, Arnold Epstein, Zvi Griliches: w6182
Published: Berndt, Ernst R., Iain M. Cockburn, Douglas L. Cocks, Arnold M. Epstein and Zvi Griliches. "Is Price Inflation Different For The Elderly? An Empirical Analysis Of Prescription Drugs," Forum for Health Economics and Policy, 1998, v1, Article 3. citation courtesy of
|April 1997||Public-Private Interaction and the Productivity of Pharmaceutical Research|
with Rebecca Henderson: w6018
Published: The Journal of Industrial Economics, vol. 46, no. 2, June 1998.
|September 1993||Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry|
with Rebecca Henderson: w4466
Published: Rand Journal of Economics, Spring 1996, 27(1), pp.32-59.
|February 1993||Generics and New Goods in Pharmaceutical Price Indexes|
with Zvi Griliches: w4272
Published: American Economic Review, vol. 84 no. 5, 1994 pp 1213-1232. citation courtesy of
|October 1992||Market Conditions and Retirement of Physical Capital: Evidence fron Oil Tankers|
with Murray Frank: w4194
|December 1987||Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and Patents|
with Zvi Griliches: w2465
Published: American Economic Review, Proceedings Issue vol. 78, no. 2, May 1988. PP. 4 19-423. citation courtesy of